Trial description:
A Phase I/II Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Olaparib (PARP inhibitor) in Patients with Advanced Solid Tumors
Contact name:
Dr Christine Parkinson
Trial start date:
Thursday, October 18, 2018
Trial end date:
Sunday, October 18, 2020
Trial tumour type:
Gynaecological
Show on Radiotherapy:
No
